Treatment Response to Lycopene in Recurrent Prostate Cancer Confirmed on 18F-Fluciclovine PET/CT

被引：0
|
作者：
Wu, Chenxi [1 ]
Marcus, Charles [1 ,4 ]
Baum, Yoram [1 ]
Kucuk, Omer [2 ,3 ]
Schuster, David M. [1 ]
机构：
[1] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Div Nucl Med & Mol Imaging, Atlanta, GA USA
[2] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA
[3] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[4] 1364 Clifton Rd NE,1st FL E163, Atlanta, GA 30322 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2023年 / 48卷 / 04期
关键词：
F-18-fluciclovine; Axumin; lycopene; PET/CT; prostate cancer; recurrence; SUPPLEMENTATION;
D O I：
10.1097/RLU.0000000000004547
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
F-18-fluciclovine (Axumin; Blue Earth Diagnostics, Ltd, Oxford, United Kingdom) PET has shown value in detecting biochemical recurrent prostatic cancer. Lycopene, a plant-based carotenoid, is reported to have potential inhibitory effect on prostate cancer, as a complementary treatment. We report a case of biochemically recurrent prostate cancer showing treatment response to lycopene as seen on an F-18-fluciclovine PET/CT correlating with serum prostate-specific antigen response.
引用
收藏
页码：361 / 363
页数：3
相关论文
共 50 条
  • [1] 18F-Fluciclovine PET in Recurrent Prostate Cancer
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (04) : 17N - 17N
  • [2] Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI
    Selnaes, Kirsten Margrete
    Kruger-Stokke, Brage
    Elschot, Mattijs
    Johansen, Hakon
    Steen, Per Arvid
    Langorgen, Sverre
    Aksnessaether, Bjorg Yksnoy
    Indrebo, Gunnar
    Sjobakk, Torill Anita Eidhammer
    Tessem, May-Britt
    Moestue, Siver Andreas
    Knobel, Heidi
    Tandstad, Torgrim
    Bertilsson, Helena
    Solberg, Arne
    Bathen, Tone Frost
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] Review of 18F-Fluciclovine PET for Detection of Recurrent Prostate Cancer
    Gusman, Mariya
    Aminsharifi, Jamie A.
    Peacock, Justin G.
    Anderson, Shane B.
    Clemenshaw, Michael N.
    Banks, Kevin P.
    RADIOGRAPHICS, 2019, 39 (03) : 822 - 841
  • [4] Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer
    Teoh, Eugene J.
    Tsakok, Maria T.
    Bradley, Kevin M.
    Hyde, Katherine
    Subesinghe, Manil
    Gleeson, Fergus V.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (10) : 803 - 804
  • [5] The positivity rates of 18F-fluciclovine and 18F-choline PET/CT in men with recurrent prostate cancer
    Lovrec, P.
    Golubic, A.
    Huic, D.
    Wagner, R.
    Gabriel, S.
    Solanki, A.
    Gupta, G.
    Savir-Baruch, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S528 - S528
  • [6] Negative 18F-Piflufolastat PET/CT, But Positive 18F-Fluciclovine PET/CT, in a Patient With Biochemically Recurrent Prostate Cancer
    Ulaner, Gary A.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (10) : 968 - 970
  • [7] Cavernosal Metastasis From Prostate Cancer on 18F-Fluciclovine PET/CT
    Nguyen, Ba D.
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (10) : E449 - E450
  • [8] Best Practices for 18F-Fluciclovine PET/CT Imaging of Recurrent Prostate Cancer: A Guide for Technologists
    Tade, Funmilayo I.
    Sajdak, Rebecca A.
    Gabriel, Mehdat
    Wagner, Robert H.
    Savir-Baruch, Bital
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2019, 47 (04) : 282 - 287
  • [9] Isolated Intravascular Prostate Carcinoma Recurrence Confirmed With 18F-Fluciclovine PET/CT and MRI
    Agely, Ali
    Sharma, Akash
    Parent, Ephraim E.
    Nawaz, Anem
    Jain, Manoj K.
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (06) : 442 - 443
  • [10] UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging
    Afaq, Asim
    Gleeson, Fergus
    Scarsbrook, Andrew
    Bradley, Kevin
    Subesinghe, Manil
    Macpherson, Ruth
    Haroon, Athar
    Patel, Neel
    Chua, Sue
    Wong, Wai-Lup
    Vinjamuri, Sobhan
    Warbey, Victoria S.
    Cook, Gary J.
    Bomanji, Jamshed
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (07) : 662 - 674
12345